FDA-Drug2026-03-11Class IICHEMICAL
Teva metoprolol succinate 200 mg tablets recalled for failed dissolution
What this means
Teva Pharmaceuticals is recalling specific lots of metoprolol succinate extended-release 200 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could affect how well the blood pressure medication works. No injuries have been reported.
- Check if your metoprolol succinate 200 mg bottle matches lot numbers 0686H251, 0687H251, or 10688H251 with expiration 02/2027 (NDC 45963-678-11)
- If you have an affected bottle, contact your pharmacy or doctor before stopping the medication
- Do not stop taking your blood pressure medication without medical guidance
- Return the recalled bottle to your pharmacy
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide
Affected count
19,056 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0357-2026More Teva recalls
- FDA-Drug2026-09-09Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.